BBVA USA Bancshares’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $236K | Sell |
1,543
-842
| -35% | -$129K | 0.01% | 511 |
|
|
2020
Q4 | $372K | Sell |
2,385
-56
| -2% | -$8.74K | 0.02% | 434 |
|
|
2020
Q3 | $278K | Sell |
2,441
-188
| -7% | -$21.4K | 0.02% | 454 |
|
|
2020
Q2 | $295K | Buy |
2,629
+188
| +8% | +$21.1K | 0.02% | 448 |
|
|
2020
Q1 | $219K | Sell |
2,441
-295
| -11% | -$26.5K | 0.02% | 447 |
|
|
2019
Q4 | $296K | Buy |
+2,736
| New | +$296K | 0.02% | 452 |
|
|
2019
Q3 | – | Sell |
-2,086
| Closed | -$273K | – | 518 |
|
|
2019
Q2 | $273K | Buy |
2,086
+349
| +20% | +$45.7K | 0.02% | 466 |
|
|
2019
Q1 | $235K | Buy |
+1,737
| New | +$235K | 0.01% | 476 |
|
|
2018
Q4 | – | Sell |
-1,570
| Closed | -$218K | – | 542 |
|
|
2018
Q3 | $218K | Buy |
+1,570
| New | +$218K | 0.01% | 512 |
|
|
2017
Q1 | – | Sell |
-1,869
| Closed | -$229K | – | 558 |
|
|
2016
Q4 | $229K | Sell |
1,869
-414
| -18% | -$50.7K | 0.02% | 509 |
|
|
2016
Q3 | $280K | Sell |
2,283
-132
| -5% | -$16.2K | 0.02% | 469 |
|
|
2016
Q2 | $282K | Sell |
2,415
-544
| -18% | -$63.5K | 0.02% | 448 |
|
|
2016
Q1 | $412K | Sell |
2,959
-519
| -15% | -$72.3K | 0.03% | 382 |
|
|
2015
Q4 | $664K | Buy |
3,478
+601
| +21% | +$115K | 0.05% | 298 |
|
|
2015
Q3 | $450K | Buy |
2,877
+1,080
| +60% | +$169K | 0.04% | 335 |
|
|
2015
Q2 | $325K | Buy |
+1,797
| New | +$325K | 0.02% | 418 |
|